Podcasts about Catheter

In this episode of The Lead, host Sandeep A. Saha, MD, MS, FHRS, is joined by Babak Nazer, MD, and Rajesh Kabra, MD, FHRS, to discuss the journal article, Safety and Effectiveness of a Dual-Energy Focal Ablation Catheter to Treat Paroxysmal Atrial Fibrillation: 6-Month Results of the FlexPulse IDE Study. Together, they review the study's six-month findings and explore the safety and effectiveness of a dual-energy focal ablation catheter for the treatment of paroxysmal atrial fibrillation. Learning Objectives Review the six-month results of the FlexPulse IDE Study evaluating a dual-energy focal ablation catheter for the treatment of paroxysmal atrial fibrillation. Discuss the safety outcomes reported in the study and their implications for clinical practice. Examine the effectiveness findings of the dual-energy focal ablation approach in patients with paroxysmal atrial fibrillation. Podcast Contributors Sandeep A Saha, MD, MS, FHRS  Babak Nazer, MD Rajesh Kabra, MD, FHRS   Host and Contributor Disclosure(s): S. Saha• Honoraria/Speaking/Consulting Fee/Speaker's Bureau: Medtronic, Inc. B. Nazer •Honoraria/Speaking/Consulting Fee: Edwards Lifesciences, Biosense Webster, Inc., Siemens Healthineers •Research: Siemens Healthineers R. Kabra •Honoraria/Speaking/Consulting Fee: AtriCure, Inc., Biosense Webster, Inc., Milestone Pharmaceuticals, AltaThera Pharmaceuticals •Research: Abbott Medical, Medtronic, Inc.  

What happens when the heart's electrical system spirals into a life-threatening rhythm disorder? In this episode of Beyond the Rounds, we explore ventricular arrhythmias — dangerous heart rhythm disturbances that can lead to sudden cardiac death, repeated ICD shocks and severe heart failure complications. Dr. Nolan Fisher sits down with cardiac electrophysiologist Dr. Peter Weiss to break down how these arrhythmias develop, why they are so difficult to treat and how new ablation technologies are changing outcomes for patients with complex ventricular tachycardia (VT).Dr. Weiss, Director of the Center for Ventricular Arrhythmias and Robotics at Banner – University Medical Center Phoenix, shares how advanced mapping systems, catheter ablation and emerging technologies like ultra-cold cryoablation, AI-guided mapping and robotic magnetic navigation are helping physicians target dangerous electrical circuits deep within the heart muscle. The discussion also explores how Banner Health is building a multidisciplinary referral center capable of rapidly managing critically ill patients experiencing VT storm and recurrent ICD shocks.This episode is designed for physicians, advanced practice providers and clinicians seeking a practical understanding of ventricular arrhythmias, advanced electrophysiology procedures and the evolving role of catheter ablation in complex cardiac care.What We Cover• The difference between ventricular arrhythmias and atrial fibrillation (AFib)• Why ventricular tachycardia (VT) can become life-threatening• How scar tissue and cardiomyopathy create electrical “short circuits”• Understanding PVCs (premature ventricular contractions) and when they should be treated• How electrophysiologists map the heart's electrical system in real time• What catheter ablation actually does during a VT procedure• The role of ICDs (implantable cardioverter defibrillators)• Why antiarrhythmic medications like amiodarone can be difficult long term• How robotic magnetic navigation improves catheter stability and maneuverability• AI-assisted mapping and machine learning in electrophysiology• New technologies including ultra-cold cryoablation and pulsed field ablation• The importance of multidisciplinary VT storm programs and rapid referral pathwaysKey Topics for Clinicians• Ventricular tachycardia (VT)• Ventricular arrhythmias• VT storm• Cardiac electrophysiology• Catheter ablation• Robotic catheter navigation• Premature ventricular contractions (PVCs)• Implantable cardioverter defibrillators (ICDs)• Pulsed field ablation• Cryoablation• AI-guided electrophysiology mapping• Ischemic cardiomyopathy• Advanced heart failure• Electrophysiology mapping systems• Structural heart disease• Sudden cardiac death preventionAbout Our GuestDr. Peter Weiss is a cardiac electrophysiologist and Director of the Center for Ventricular Arrhythmias and Robotics at Banner – University Medical Center Phoenix and the University of Arizona College of Medicine – Phoenix. He specializes in complex ventricular arrhythmia management, robotic catheter ablation and advanced electrophysiology procedures. Dr. Weiss trained at Stanford University and has performed more than 1,400 robotic ablation procedures. Prior to joining Banner Health, he spent 14 years building a regional ventricular arrhythmia referral program at Intermountain Health.How to Refer a PatientBanner Health providers: Use Cerner's Ambulatory Referral Management (ARM) tool.Community providers: Please call 602-521-3090 for referral information and scheduling assistance.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.

In this episode, CardioNerds Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Yong Hao Yeo are joined by electrophysiology expert Dr. Bradley Knight to discuss atrial fibrillation (AF) management in challenging clinical scenarios. We explore arrhythmias in patients with pre-excitation syndromes, particularly Wolff-Parkinson-White (WPW) syndrome, and strategies for rhythm control. We also discuss AF management in pregnancy, adult congenital heart disease, and patients with tachycardia-bradycardia (tach-brady) syndrome. This episode provides essential insights into nuanced decision-making for the care of patients with complex arrhythmia profiles. Audio editing by CardioNerds academy intern, Grace Qiu. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! PEARLS AF in WPW is a true emergency—AV nodal blocking agents can be deadly. In patients with WPW syndrome, AF can rapidly conduct through the accessory pathway, risking ventricular fibrillation and sudden death. Avoid AV nodal blockers like beta-blockers and calcium channel blockers. Catheter ablation is the first-line rhythm control strategy in WPW. Catheter ablation carries a Class I recommendation and offers >90% success. If antiarrhythmic drugs are needed, sodium channel blockers like flecainide or propafenone are preferred in patients without structural heart disease. In pregnancy, protecting the mother is protecting the fetus. An unstable mother means an unstable fetus. Rate control is the first step in AF with rapid ventricular responses and electrical cardioversion is safe when needed. Multidisciplinary care is essential. AF in congenital heart disease is often outside the pulmonary veins. Surgical scars and chamber remodeling in ACHD patients often lead to AF from non-pulmonary vein foci. Electrogram-based mapping and targeted ablation strategies are essential to increase success rate of durable rhythm control. Tachy-brady syndrome may require pacing to unlock therapy. AF may cause atrial myopathy and sinus node dysfunction. These patients often require permanent pacing to allow safe use of rate-controlling medications like beta-blockers and to prevent syncope or chronotropic incompetence. Notes: Notes drafted by Dr. Yong Hao Yeo Why is atrial tachycardia in patients with WPW syndrome dangerous? Patients with WPW commonly present with supraventricular tachycardia (SVT) due to atrioventricular reentrant circuits, either orthodromic or antidromic. This SVT can degenerate into AF. In the absence of AV nodal as the governor between the atrium and ventricles, the accessory pathway may conduct impulses rapidly and frequently. This can lead to dangerously high ventricular rates, predisposing patients to ventricular fibrillation and sudden cardiac arrest. What are some strategies for rhythm control in patients with WPW and atrial tachycardia? Catheter ablation is the first-line therapy (Class I recommendation), with a success rate of over 90%. Ablation reduces the risk of sudden cardiac arrest, though some patients may remain prone to AF. If ablation is not feasible/ contraindicated, sodium channel blockers such as flecainide and propafenone are good options in patients without ischemia or structural heart disease (Class IIa recommendation). Amiodarone should be avoided because it has a long half-life, can accumulate in the system, and may delay definitive treatment with catheter ablation. AV nodal blocking agents like beta blockers and calcium channel blockers should be avoided, as they are less effective at controlling ventricular rate in WPW and can increase conduction over the accessory pathway. These agents can also exacerbate the risk of rapid ventricular rates during AF and worsen left ventricular function. What are some special considerations in managing AF in pregnant patients? The primary goal in managing cardiovascular disease during pregnancy is to protect the mother, as fetal outcomes depend on maternal well-being. Therefore, while caution is necessary, we should avoid undertreating pregnant patients with AF. In cases of AF with rapid ventricular response (RVR), rate control is usually the first-line strategy, with beta blockers preferred over digoxin or non-dihydropyridine calcium channel blockers. It is then reasonable to initially observe for spontaneous conversion in stable patients. Antiarrhythmic drugs (AADs) are generally avoided during the first trimester, but clinical judgment on a case-by-case basis is essential. Evidence for the safety of AADs in pregnancy is limited, often derived from their use in other conditions such as fetal SVT. Flecainide and sotalol are reasonable options for rhythm control (Class IIa recommendation). Electrical cardioversion is considered safe in pregnancy and should be utilized when indicated (Do not forget!). There is no pregnancy-specific thromboembolic risk stratification tool. CHA₂DS₂-VASc scoring and the presence of risk factors like mitral stenosis can help guide anticoagulation decisions, though the magnitude of thromboembolic risk during pregnancy remains unclear. Rate control agents are typically continued during delivery due to the increased physiologic stress of labor and delivery. Multidisciplinary care is crucial and should involve obstetrics, maternal-fetal medicine, cardiology, and electrophysiology specialists. What are some key considerations for AF management in patients with adult congenital heart disease (ACHD)? Patients with repaired congenital heart disease are at increased risk for arrhythmias due to two main factors: surgical scars that create arrhythmogenic foci and mechanical remodeling of the atria or ventricles resulting from the underlying disease. In these patients with structural heart disease, sodium channel blockers may not be ideal antiarrhythmic options. When selecting an antiarrhythmic drug, clinicians must consider the nature of structural or surgical impairments, such as right bundle branch block or prolonged QT interval. It is also essential to assess renal and hepatic function (often impaired in patients with ACHD) to ensure appropriate metabolism and clearance of antiarrhythmic medications. Electrogram-based ablation strategies (those leveraging artificial intelligence are developing!) may help identify effective ablation targets, which are often outside the pulmonary veins in patients with ACHD. These individualized approaches can improve ablation success rates in this complex patient population. What makes tachycardia-bradycardia (tach-brady) syndrome a unique challenge in arrhythmia management? Patients who present with both AF and bradycardia, especially with syncope, require a thoughtful diagnostic approach to identify the underlying rhythm disturbance. Extended cardiac monitoring, including event monitors or implantable loop recorders, can help capture intermittent arrhythmias and correlate them with symptoms. AF may lead to atrial myopathy, and since the sinus node resides within the atrium, this can result in sinus node dysfunction—a hallmark of tachy-brady syndrome. Following spontaneous conversion from AF to sinus rhythm, sinus node dysfunction may persist, leading to prolonged pauses or chronotropic incompetence. Management becomes more complex when beta-blockers are needed for AF with RVR, as they can exacerbate bradycardia. Permanent pacemaker implantation is often the next step to consider. Permanent pacemaker implantation is often considered to facilitate safe rate control in these cases. In younger patients, aggressive AF burden reduction may prevent atrial remodeling and the development of true atrial myopathy, potentially avoiding pacemaker implantation. References Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). doi:https://doi.org/10.1161/CIR.0000000000001193 ‌ Van IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2024;45(36). doi:https://doi.org/10.1093/eurheartj/ehae176 ‌ Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm. Published online May 1, 2023. doi:https://doi.org/10.1016/j.hrthm.2023.05.017 ‌ Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary. Journal of the American College of Cardiology. 2019;73(12):1494-1563. doi:https://doi.org/10.1016/j.jacc.2018.08.1028 ‌

For patient referrals: call 602-521-3661What happens when the heart's electrical system spirals into a life-threatening rhythm disorder? In this episode of Beyond the Rounds, we explore ventricular arrhythmias — dangerous heart rhythm disturbances that can lead to sudden cardiac death, repeated ICD shocks and severe heart failure complications. Dr. Nolan Fisher sits down with cardiac electrophysiologist Dr. Peter Weiss to break down how these arrhythmias develop, why they are so difficult to treat and how new ablation technologies are changing outcomes for patients with complex ventricular tachycardia (VT).Dr. Weiss, Director of the Center for Ventricular Arrhythmias and Robotics at Banner – University Medical Center Phoenix, shares how advanced mapping systems, catheter ablation and emerging technologies like ultra-cold cryoablation and pulsed field ablation are helping physicians target dangerous electrical circuits deep within the heart muscle. The discussion also explores how Banner Health is building a multidisciplinary referral center capable of rapidly managing critically ill patients experiencing VT storm and recurrent ICD shocks.This episode is designed for physicians, advanced practice providers and clinicians seeking a practical understanding of ventricular arrhythmias, advanced electrophysiology procedures and the evolving role of catheter ablation in complex cardiac care.What We Cover• The difference between ventricular arrhythmias and atrial fibrillation (AFib)• Why ventricular tachycardia (VT) can become life-threatening• How scar tissue and cardiomyopathy create electrical “short circuits”• Understanding PVCs (premature ventricular contractions) and when they should be treated• How electrophysiologists map the heart's electrical system in real time• What catheter ablation actually does during a VT procedure• The role of ICDs (implantable cardioverter defibrillators)• Why antiarrhythmic medications like amiodarone can be difficult long term• New technologies including ultra-cold cryoablation and pulsed field ablation• The importance of multidisciplinary VT storm programs and rapid referral pathwaysKey Topics for Clinicians• Ventricular tachycardia (VT)• Ventricular arrhythmias• VT storm• Cardiac electrophysiology• Catheter ablation• Premature ventricular contractions (PVCs)• Implantable cardioverter defibrillators (ICDs)• Pulsed field ablation• Cryoablation• Ischemic cardiomyopathy• Advanced heart failure• Electrophysiology mapping systems• Structural heart disease• Sudden cardiac death preventionAbout Our GuestDr. Peter Weiss is a cardiac electrophysiologist and Director of the Center for Ventricular Arrhythmias and Robotics at Banner – University Medical Center Phoenix and the University of Arizona College of Medicine – Phoenix. He specializes in complex ventricular arrhythmia management, robotic catheter ablation and advanced electrophysiology procedures. Dr. Weiss trained at Stanford University and completed additional advanced electrophysiology training at the University of Pennsylvania. Prior to joining Banner Health, he spent 14 years building a regional ventricular arrhythmia referral program at Intermountain Health.How to Refer a PatientBanner Health providers: Use Cerner's Ambulatory Referral Management (ARM) tool.Community providers: Please call 602-521-3661 for referral information and scheduling assistance.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.Subscribe to Beyond the Rounds for physician-focused conversations on clinical innovation, specialty collaboration and evolving standards of care.

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by integrated vascular surgery resident Falen Demsas, 5th-year general surgery resident Sasank Kalipatnapu (@ksasank), JVS editor Dr. Duncan (@ADuncanVasc), and JVS-VL editor Dr. Ruth Bush to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Weaver, student doctor Finn, Dr. Sridharan, and Dr. Anan.    Articles:   Evaluating the Vascular Quality Initiative's role in advancing minority health and health disparities research―a scoping review Catheter-directed interventions versus surgical embolectomy in massive pulmonary embolism    Show Guests  Dr. Weaver: assistant professor of surgery and associate program director of the vascular surgery fellowship at the University of Utah. She is also the director of clinical operations efficiency at the University of Utah.  Finn Repella: rising 4th medical student at the University of Virginia Dr. Sridharan: associate professor at the University of Pittsburgh Medical Center (UPMC). Site Chief of vascular surgery at UPMC Mercy. Dr. Anan: research fellow in the division of vascular surgery at the University of Pittsburgh Medical Center (UPMC). She earned her MD from the American University of Beirut.    Notable mentions: From Bench to Bill: How a Transplant Nuance Became 1 of Only 57 Laws Passed in 2013   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.   *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.  

When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In this episode of the BackTable Podcast, Netherlands interventional oncologist Dr. Maarten (M.L.J.) Smits shares a step-by-step walkthrough of the new hepatic arteriography and C-arm CT–guided ablation (HepACAGA) technique, punctuated with a real-world case series at the end. Find out how intra-arterial contrast, cone-beam CT, and 3D needle guidance can improve tumor conspicuity, targeting accuracy, and ablation margin assessment within a single angiography suite. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:55 - Netherlands Tech Access04:31 - Origin of HepACAGA07:14 - Why Use a Catheter?11:24 - Tools and Setup13:13 - Catheters and Devices17:06 - Contrast Protocol Basics22:51 - Targeting and Needle Guidance31:09 - Patient Selection35:56 - Extra Benefits and Multimodal39:58 - Workflow and Outcomes46:14 - Evidence and Early Studies51:41 - Rethinking Size Cutoffs57:54 - HCC Case Walkthrough01:02:27 - Hard-to-See Metastasis01:06:22 - Margin Driven Reablation01:11:04 - Bleeding and Embolization01:16:05 - Renal ACAGA Expansion01:23:31 - Adoption and Next Steps --- More about this episode Dr. Smits explains the origins of HepACAGA and why catheter-based contrast delivery can meaningfully change ablation planning, particularly for small lesions, poorly visualized tumors, and cases where ultrasound or conventional CT guidance may be insufficient. He walks through the practical setup, including catheter positioning, contrast dilution, timing protocols, needle navigation, apnea/end-expiration technique, and built-in fusion for immediate ablation verification. He also describes how the angio suite environment supports multimodal treatment, including intraprocedural embolization when bleeding occurs or when additional transarterial therapy is needed. The episode also examines early outcomes from Dr. Smits' group, including a reported reduction in local recurrence from approximately 25% to 5%, with a modest increase in procedure time. Case examples include HCC, small colorectal liver metastases, margin-driven re-ablation, hemorrhage management, and extension of the ACAGA concept to renal tumors (RenACAGA). --- Resources Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA) to Improve Tumor Visualization, Navigation and Margin Confirmation in Percutaneous Liver Tumor Ablationhttps://pubmed.ncbi.nlm.nih.gov/37704863/ Renal Arteriography and C-arm CT-Guided Ablation (RenACAGA) for Thermal Ablation of Challenging Renal Tumorshttps://pubmed.ncbi.nlm.nih.gov/40295401/ --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Full article: Catheter-Directed Sclerotherapy Versus Ovarian Cystectomy for Unilateral Ovarian Endometrioma: A Pilot Randomized Controlled Trial Cystectomy as conventional treatment for ovarian endometrioma can lower ovarian reserve. Tobi Folami, MD, discusses the AJR article by Hwan et al. that presents a randomized controlled trial comparing cystectomy with catheter-directed sclerotherapy for treating unilateral endometriomas.

God will help you in any situation you find yourself in. -------- Thank you for listening! Your support of Joni and Friends helps make this show possible.     Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org   Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more accurately assess lesions, determine the appropriate stent size, and ensure proper placement, thereby reducing cardiac death and blood clots around stents. Tim explains, "So our technology is an imaging catheter. We're unique in that we combine two imaging modalities that are already well established in the market. But because each of them has blind spots, by combining them into a single catheter, we remove those blind spots, and we think we produce the best imaging catheter to help guide coronary interventions."   "It is well known that these strengths and weaknesses occur in both ultrasound and optical imaging. But to set the stage, this is a trend happening in the marketplace. There are four million angioplasty stenting procedures performed each year, and most of them rely solely on traditional angiography. Most of your audience probably knows that angiography is an X-ray that uses a contrast agent, so you're seeing the vasculature around the heart through a secondary image. The detailed view inside the blood vessels is limited when using only angiography, which has restricted the types of procedures doctors have been able to perform over time. Recognizing that intravascular ultrasound, sometimes called IVUS, and separately, OCT—short for optical coherence tomography—were developed independently to examine inside the blood vessel." #Conavi #CardiovascularImaging #InterventionalCardiology #MedicalDevice #HeartHealth #Innovation #IVUS #OCT #AIinHealthcare #CardiacIntervention #HealthTech #Medtech #Cardiology #HybridImaging Conavi.com Download the transcript here  

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more accurately assess lesions, determine the appropriate stent size, and ensure proper placement, thereby reducing cardiac death and blood clots around stents. Tim explains, "So our technology is an imaging catheter. We're unique in that we combine two imaging modalities that are already well established in the market. But because each of them has blind spots, by combining them into a single catheter, we remove those blind spots, and we think we produce the best imaging catheter to help guide coronary interventions."   "It is well known that these strengths and weaknesses occur in both ultrasound and optical imaging. But to set the stage, this is a trend happening in the marketplace. There are four million angioplasty stenting procedures performed each year, and most of them rely solely on traditional angiography. Most of your audience probably knows that angiography is an X-ray that uses a contrast agent, so you're seeing the vasculature around the heart through a secondary image. The detailed view inside the blood vessels is limited when using only angiography, which has restricted the types of procedures doctors have been able to perform over time. Recognizing that intravascular ultrasound, sometimes called IVUS, and separately, OCT—short for optical coherence tomography—were developed independently to examine inside the blood vessel." #Conavi #CardiovascularImaging #InterventionalCardiology #MedicalDevice #HeartHealth #Innovation #IVUS #OCT #AIinHealthcare #CardiacIntervention #HealthTech #Medtech #Cardiology #HybridImaging Conavi.com Listen to the podcast here  

In this episode of AUANews Inside Tract's Igniting Discovery series, AUA's Research Grants Program Sr. Manager, Sarah Gross, speaks with Bryan Pinchuk, founder and CEO of InnoCare Urologics and a winner of the 2025 AUA Innovation Nexus Showcase. Pinchuk shares how his team redesigned the Foley catheter with a safety valve that automatically deflates when accidentally pulled, reducing injury risk for patients and clinicians. He also discusses the inspiration behind the device, the path to FDA clearance, what he learned at AUA Innovation Nexus, and lessons for early-stage medical device innovators. Learn more about Innovation Nexus: https://www.auanexus.org/

We are unbelievably excited this week to be reviewing the hot-off-the-presses 2026 Multi-Society (AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN) Pulmonary Embolism Guidelines with lead author Dr. Mark A. Creager. We will talk about key updates in these guidelines compared to prior practice, including the new risk classification model, and provide an overview from diagnosis to follow-up. Given the clinical importance and prevalence of pulmonary embolism, these guidelines are certainly going to shape practice going forward, so this episode is a can’t miss! Watch the full video of this episode with graphics and helpful teaching visuals on our YouTube channel: https://www.youtube.com/@pulmpeeps Meet Our Guest Dr. Mark Creager is a Professor of Medicine at Dartmouth Hitchcock Medical Center where he specializes in Cardiovascular Medicine with an emphasis on venous thromboembolic disease. He served as the lead author of the 2026 Pulmonary Embolism Guidelines. Article and Reference Creager MA, Barnes GD, Giri J, Mukherjee D, Jones WS, Burnett AE, Carman T, Casanegra AI, Castellucci LA, Clark SM, Cushman M, de Wit K, Eaves JM, Fang MC, Goldberg JB, Henkin S, Johnston-Cox H, Kadavath S, Kadian-Dodov D, Keeling WB, Klein AJP, Li J, McDaniel MC, Moores LK, Piazza G, Prenger KS, Pugliese SC, Ranade M, Rosovsky RP, Russo F, Secemsky EA, Sista AK, Tefera L, Weinberg I, Westafer LM, Young MN. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Feb 19:S0735-1097(25)10161-7. doi: 10.1016/j.jacc.2025.11.005. Epub ahead of print. PMID: 41712898. Key Learning Points Why these guidelines matter: This is the first joint AHA/ACC clinical practice guideline specifically on acute PE, bringing together a truly multidisciplinary writing committee (cardiology, pulmonology, hematology, emergency medicine, interventional radiology, surgery, and others). Prior guidelines existed from individual societies, but nothing this comprehensive had been updated in roughly five to six years. New PE clinical categories (A through E): One of the most impactful changes is replacing the old “massive/submassive” and “low/intermediate/high risk” labels with five categories that form a severity continuum. Category A is subclinical (incidental PE found on imaging in asymptomatic patients). Category B covers symptomatic but low-severity patients. Category C is where much of the clinical complexity lives — symptomatic, hemodynamically stable patients subdivided into C1, C2, and C3 based on RV function and biomarkers. Category D represents incipient cardiopulmonary failure (transient hypotension, normotensive shock with end-organ dysfunction). Category E is frank cardiopulmonary failure, with E2 being the sickest — refractory or recurrent cardiac arrest. Respiratory modifiers (hypoxia requiring supplemental oxygen) layer onto C, D, and E. Diagnostic approach: Clinical evaluation comes first — history, exam, and validated decision tools (Wells score, revised Geneva, PERC). If clinical probability is low and D-dimer is normal, imaging can be safely avoided. If either is concerning, imaging is warranted. CTPA remains the preferred imaging modality due to superior sensitivity, specificity, wide availability, and ability to assess clot burden and alternative diagnoses. VQ scanning is still appropriate when CTPA is contraindicated, and VQ SPECT offers better reproducibility and specificity than traditional planar VQ if available. Echocardiography is not a diagnostic test for PE but is important for risk stratification — RV size, TAPSE, and tissue Doppler measures all contribute prognostic information. Anticoagulation updates: Anticoagulation remains the cornerstone of treatment. For patients potentially needing advanced therapies (C3, D, E), parenteral anticoagulation is started first. A notable recommendation: low molecular weight heparin is generally preferred over unfractionated heparin, based on evidence showing more effective VTE risk reduction, more predictable pharmacokinetics, no need for routine monitoring, lower rates of heparin-induced thrombocytopenia, and no increase in major bleeding. The committee acknowledged this may create discomfort for clinicians accustomed to unfractionated heparin’s easy reversibility, but the difficulty of achieving and maintaining therapeutic levels with UFH was a significant concern. Advanced therapies: Catheter-based thrombolysis, mechanical thrombectomy, systemic thrombolysis, and surgical embolectomy all received mostly class 2B recommendations (“can consider”) for C3 and D categories, reflecting that current evidence shows improvement in short-term surrogate measures (RV/LV ratio, hemodynamics) but lacks definitive hard outcome data on mortality. For category E1 patients, recommendations are stronger (class 2A). Multiple trials are expected soon — HI-PEITHO, PEERLESS-2, PE-TRACT, PERSEVERE, TORPEDO, and PROG — that should substantially inform future updates. PERT teams: Pulmonary embolism response teams are encouraged, particularly for C3, D, and E patients. They’ve been shown to reduce length of stay. For institutions without PERT capability, establishing consultation networks with larger centers is recommended. Post-PE follow-up: Patients shouldn’t be “left in the wilderness” after discharge. The guidelines recommend communication within the first week to ensure understanding of diagnosis and treatment, an in-person visit at or before three months to assess for persistent symptoms and discuss anticoagulation duration, ongoing surveillance for chronic thromboembolic pulmonary disease, and periodic reassessment for those on extended anticoagulation. Infographics

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting ~37.6 million people globally, with prevalence expected to double in the coming decades.    A recent Lancet Seminar (2026) highlights several key principles shaping modern AF care:   • Stroke prevention with oral anticoagulation remains the cornerstone • Early rhythm control strategies improve cardiovascular outcomes • Catheter ablation is increasingly used as first-line therapy • Lifestyle modification—weight loss, exercise, alcohol reduction—reduces AF burden • Integrated care models such as the ABC pathway and AF-CARE improve outcomes   The future of AF management is holistic, preventive, and patient-centred.   #Cardiology #AtrialFibrillation #StrokePrevention #Electrophysiology #PrecisionMedicine

What if the most powerful cancer treatments already exist — but aren't being offered because they fall outside the guidelines?In this episode of Integrative Cancer Solutions, Dr. Michael Karlfeldt sits down with world-renowned interventional radiologist and oncology innovator Dr. Syed Hasnain Haider-Shah to explore why modern cancer care often prioritizes protocols over patients. From catheter-directed chemotherapy and tumor embolization to immune-based strategies, photobiomodulation, and precision nutrition, Dr. Shah reveals how advanced cancer treatments are being used globally — especially in China — while remaining largely inaccessible in the U.S.This conversation dives deep into the limitations of chemotherapy and radiation, the intelligence of cancer stem cells, immune system suppression, cancer cachexia, and why integrative, individualized approaches give patients their best chance at long-term survival. If you or someone you love is navigating a cancer diagnosis and searching for real options beyond “standard of care,” this episode is essential listening.Key Takeaways:5:20 Radiation therapy risks and how to support recovery nutritionally11:46 Why systemic chemotherapy often fails and selects for aggressive cancer cells12:17 Catheter-directed chemotherapy: targeting tumors without poisoning the body16:25 The immune system as the most powerful anti-cancer weapon26:37 Tumor embolization: starving cancer by cutting off its blood supply34:50 Why advanced cancer therapies thrive in China but are restricted in the U.S.Resources Mentioned:Williams Cancer Institute (Mexico) – https://williamscancerinstitute.comPhotobiomodulation / Intravenous Light Therapy (General Overview) – https://pubmed.ncbi.nlm.nih.gov Want to guest on our shows?Calendly Link for Integrative Lyme Solutions: https://calendly.com/drmichaelk/integrative-lyme-solutions-podcast-interviewCalendly Link for Integrative Cancer Solutions: https://calendly.com/drmichaelk/podcast-interviewCalendly Link for Dr. K Show: https://calendly.com/drmichaelk/dr-k-show-interview Breaking Free From Lyme: A Comprehensive Guide to Healing and Recovery-URL: https://store.thekarlfeldtcenter.com/products/breaking-free-from-lyme-Price: $24.99-Discount Code: LYMEPODCASTUnleashing 10X Power: A Revolutionary Approach to Conquering Cancer-URL: https://store.thekarlfeldtcenter.com/products/unleashing-10x-power-Price: $24.99-Discount Code: CANCERPODCAST1Healing Within: Unraveling the Emotional Roots of Cancer-URL: https://store.thekarlfeldtcenter.com/products/healing-within-Price: $24.99-Discount Code: CANCERPODCAST2The Science and Spirit of Transformation: A Holistic Guide to Elevating Health, Consciousness, and Purpose-URL: https://store.thekarlfeldtcenter.com/products/the-science-and-spirit-of-transformation-Price: $24.99-Discount Code: DRKSHOWPODCAST -----------------------------------------------A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health ThreatGrab my book here: https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering CancerGet it here: https://store.thekarlfeldtcenter.com/products/unleashing-10x-powerPrice: $24.99100% Off Discount Code: CANCERPODCAST1 Healing Within: Unraveling the Emotional Roots of CancerGet it here: https://store.thekarlfeldtcenter.com/products/healing-withinPrice: $24.99100% Off Discount Code: CANCERPODCAST2-----------------------------------------------Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

Dr. Emile Daoud, Deputy Editor of JACC Clinical Electrophysiology discusses Cerebrovascular Ischemic Lesions After Pulsed Field Ablation for Atrial Fibrillation Using Variable-Loop Ablation Catheter.

"ASRA Answers: Continuous Catheter Techniques in Regional Anesthesia: How Long Is Too Long?" From ASRA Pain Medicine News, November 2025. See the original article at www.asra.com/november25news for figures and references. This material is copyrighted. Support the show

In today's VETgirl online veterinary continuing education podcast, we review the first reported case of colonic stricture formation linked to rectal Foley catheter use in a dog treated for acute hemorrhagic diarrhea syndrome. Be aware of the potential risks of an often-overlooked supportive practice used during nursing care. Tune in to learn how this information can guide safer management of rectal Foley catheters in dogs to improve in-patient hygiene and comfort!

In today's VETgirl online veterinary continuing education podcast, we review the first reported case of colonic stricture formation linked to rectal Foley catheter use in a dog treated for acute hemorrhagic diarrhea syndrome. Be aware of the potential risks of an often-overlooked supportive practice used during nursing care. Tune in to learn how this information can guide safer management of rectal Foley catheters in dogs to improve in-patient hygiene and comfort!

Send us a textWelcome back Rounds Table Listeners! In this solo episode, Dr. Mike Fralick discusses a recent trial examining whether noninvasive blood-pressure monitoring is noninferior to early insertion of an arterial catheter in patients with shock admitted to the ICU. Here we go! Deferring Arterial Catheterization in Critically Ill Patients with Shock (0:00 – 11:05).The Good Stuff (11:06 – 11:59):We've launched Critical Care Trial Files! https://criticalcaretrialfiles.substack.com/Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

CardioNerds (Dr. Kelly Arps, Dr. Naima Maqsood, and Dr. Elizabeth Davis) discuss chronic AF management with Dr. Edmond Cronin. This episode seeks to explore the chronic management of atrial fibrillation (AF) as described by the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. The discussion covers the different AF classifications, symptomatology, and management including medications and invasive therapies. Importantly, the episode explores current gaps in knowledge and where there is indecision regarding proper treatment course, as in those with heart failure and AF. Our expert, Dr. Cronin, helps elucidate these gaps and apply guideline knowledge to patient scenarios. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Review the guidelines- Catheter ablation is a Class I recommendation for select patient groups  Appropriately recognize AF stages- preAF conditions, symptomatology, classification system (paroxysmal, persistent, long-standing persistent, permanent)  Be familiar with the EAST-AFNET4 trial, as it changed the approach of rate vs rhythm control  Understand treatment approaches- lifestyle modifications, management of comorbidities, rate vs rhythm control medications, cardioversion, ablation, pulmonary vein isolation, surgical MAZE  Sympathize with patients- understand their treatment goals  Notes Notes: Notes drafted by Dr. Davis.    What are the stages of atrial fibrillation?   The stages of AF were redefined in the 2023 guidelines to better recognize AF as a progressive disease that requires different strategies at the different therapies  Stage 1 At Risk for AF: presence of modifiable (obesity, lack of fitness, HTN, sleep apnea, alcohol, diabetes) and nonmodifiable (genetics, male sex, age) risk factors associated with AF  Stage 2 Pre-AF: presence of structural (atrial enlargement) or electrical (frequent atrial ectopy, short bursts of atrial tachycardia, atrial flutter) findings further pre-disposing a patient to AF  Stage 3 AF: patient may transition between these stages  Paroxysmal AF (3A): intermittent and terminates within ≤ 7 days of onset  Persistent AF (3B): continuous and sustained for > 7 days and requires intervention  Long-standing persistent AF (3C): continuous for > 12 months   Successful AF ablation (3D): freedom from AF after percutaneous or surgical intervention  Stage 4 Permanent AF: no further attempts at rhythm control after discussion between patient and clinician   The term chronic AF is considered obsolete and such terminology should be abandoned   What are common symptoms of AF?   Symptoms vary with ventricular rate, functional status, duration, and patient perception  May present as an embolic complication or heart failure exacerbation  Most commonly patients report palpitations, chest pain, dyspnea, fatigue, or lightheadedness. Vague exertional intolerance is common  Some patients also have polyuria due to increased production of atrial natriuretic peptide  Less commonly can present as tachycardia-associated cardiomyopathy or syncope  Cardioversion into sinus rhythm may be diagnostic to help determine if a given set of symptoms are from atrial fibrillation to help guide the expected utility of more aggressive rhythm control strategies.   What are the current guidelines regarding rhythm control and available options?  COR-LOE 1B: In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function   COR-LOE 2a-B: In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function. In patients with a recent diagnosis of AF (

Boris' Pronunciation Full Face of Samples When Did A Freebie Bite You In The Ass? Top 5 Records Before Google Maps How Did We Get By Without… Music Quiz: Carrie - Leona Lewis Diane Keaton’s Dogs Ryan Adams Juices Zoe’s Permanent BraceletSubscribe on LiSTNR: https://play.listnr.com/podcasts/carrie-and-tommySee omnystudio.com/listener for privacy information.

In honor of Joni's birthday, join us in spreading the Gospel around the world to people with disabilities who really need the hope of Christ. Help us celebrate here! --------Thank you for listening! Your support of Joni and Friends helps make this show possible. Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org. Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

Got pain that last for a looooong time? YOU, my friend, need a continuous catheter! Join Amit and Jeff as they discuss all things catheter-related: What is the best way to place them? How do keep them from falling out? What are the differences in catheter and pump designs? Is a programmed intermittent bolus enough? Or do we need a background rate too? What is a 'green gizmo'? Why does Jeff keep attempting accents? So many questions--and SO MANY answers! Stay tuned for all this and much more as we pump it up in this fun and enlightening episode.  Join us each month for another sassy conversation about anesthesiology, emergency medicine, critical care, POCUS, pain medicine, ultrasound guided nerve blocks, acute pain, and perioperative care!    Links:  

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography-Based Device Compared to Invasive Pulmonary Artery Catheter.

Host Dr. Tushar Chopra and guest Dr. Aisha Shaikh discuss the importance of good techniques for connecting and disconnecting HD catheters, review catheter locking solutions and novel caps, and consider new data released since the 2019 KDIGO guidelines.

Host Dr. Tushar Chopra and guest Dr. Aisha Shaikh discuss the importance of good techniques for connecting and disconnecting HD catheters, review catheter locking solutions and novel caps, and consider new data released since the 2019 KDIGO guidelines.

Send us a textIn this episode of our podcast DocTalk, host Debra Schindler sits down with MedStar Health interventional cardiologist Dr. John Wang, director of the Cardiac Catheterization Labs at MedStar Union Memorial Hospital and MedStar Franklin Square Medical Center in Baltimore, to explore how cardiac catheterizations have evolved, and why the transradial approach (through the wrist) is transforming catheterization procedures.Traditionally performed through the femoral artery in the groin, cardiac caths are increasingly going in through the wrist, offering: ·       Faster recovery Fewer complications Greater patient comfort Same-day discharge for many patientsDr. Wang explains:What symptoms may lead to a cardiac cathWhen the procedure is performed in emergencies (like heart attacks) vs. scheduled careWhy national cardiology guidelines recommend the transradial approachWhat patients should ask their doctors before undergoing the procedureIf you or a loved one may need a heart cath, this episode will help you understand your options, and why the accessing the heart through the wrist is a better approach.Learn more about interventional cardiology at MedStarHealth.org/MHVI To comment on this podcast, or suggest a topic for another episode send us an email: DocTalk@medstar.netFor more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Texas State Senator Carol Alvarado, a Democrat from Houston, made headlines with her dramatic plan to filibuster a Republican-backed redistricting bill - going so far as to wear a catheter to stay on the Senate floor as long as possible. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode, host Dr. Tushar Chopra and guest Dr. Namrata Krishnan will discuss how to safely connect and disconnect HD catheters, common myths about catheter care in hemodialysis, and showering with a dialysis catheter.

In this episode, host Dr. Tushar Chopra and guest Dr. Namrata Krishnan will discuss how to safely connect and disconnect HD catheters, common myths about catheter care in hemodialysis, and showering with a dialysis catheter.

No topics are off the table, hilarious, unscripted, and unhinged. The Dicks tackle the three essential male needs, the horrors of dating in your 50s, and the logistics of using the “lemonade pitcher” to avoid getting out of bed to pee. Grab a beer and belly up to the bar.

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly patients are discussed by John Mandola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I SURPASS CVOT This Week in Cardiology Podcast, August 1 https://www.medscape.com/viewarticle/1002781 Mounjaro Appears More Heart Protective Than Trulicity in Trial Of Eli Lilly Diabetes Drugs https://www.medscape.com/s/viewarticle/mounjaro-proves-more-heart-protective-than-trulicity-trial-2025a1000kct II Catheter and Surgical AF ablation Catheter and Surgical Ablation for AF: Meta-Analysis https://www.acpjournals.org/doi/10.7326/ANNALS-25-00253 III Watchman Air Embolism Alerts Looming Pay Cut to LAAO Triggers Objection From Card Groups https://www.medscape.com/viewarticle/looming-pay-cut-laao-triggers-objection-card-groups-2025a1000l0j FDA Alert https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-watchman-access-system-issue-boston-scientific IV Switching Oral Anticoagulants in Frail Older Adults Patients FRAIL AF Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.066485 COMBINE AF Substudy https://doi.org/10.1016/j.jacc.2025.05.060 The Most Important Study From ESC: FRAIL-AF https://www.medscape.com/viewarticle/996063 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Which imaging and treatment techniques are optimal for GAE in the OBL? In this BackTable Brief, Dr. Osman Ahmed and Dr. Sid Padia explore instrument selection and CT techniques in the OBL for genicular artery embolization (GAE).  Dr. Ahmed and Dr. Padia discuss the importance of not compromising on patient safety, and the careful selection of their approach to treatment. They further elaborate on the use of cone beam CT for more precise treatment planning, sharing insights on catheter selection, contrast solutions, and best practices for ensuring high-quality patient care, especially in the OBL (office-based lab) setting. Episode Outline 00:00 - Introduction  00:53 - Discussion on Catheter Selection and Preference  03:37 - Use of Cone Beam CT in the OBL 10:42 - Cone Beam CT Protocols and Technique: Selective or Non-Selective? 12:38 - Contrast Solutions and Techniques Resources Dr. Venkatesh, “Kavi”, Krishnasamy, MD https://www.uab.edu/medicine/radiology/faculty/intervent-radiology/profile/krishnasamy  Dr. Osman Ahmed, MD https://bucksbauminstitute.uchicago.edu/bio/osman-ahmed-md/  Dr. Siddarth, “Sid”, Padia, MD https://www.uclahealth.org/providers/siddharth-padia

Welcome to The Doula's Guide To... Podcast, season 3 episode 13. Today I wanted to chat to you about something that I'm hearing people being told often - that inductions are risk free, or "not very risky". I wanted to break this down into different methods so this episode focuses on the balloon catheter and the risks associated with this form of induction.*Please note this podcast is not medical advice and not meant to influence your decision making process, it is merely to present you with more information to help you make informed decisions that feel right for you*Links mentioned in this episode:A snapshot of women's and clinicians' perceptions of the double balloon catheter for induction of labor: click hereWomenʼs reflections on induction of labour and birthing interventions and what they would do differently next time: click herePatient satisfaction with the cervical ripening balloon as a method for induction of labour: a randomised controlled trial: click hereRisk of maternal, fetal and neonatal complications associated with the use of the transcervical balloon catheter in induction of labour: click herePatient information leaflet: click hereReddit thread "Foley Balloon Induction Experiences": click hereClick here to find out more about my digital hypnobirthing courses: ⁠⁠⁠⁠⁠⁠⁠⁠thedungareedoula.co.uk/onlinecourse⁠⁠⁠⁠⁠⁠⁠⁠Use code 'PODCAST' for 20% off my digital courses!Sign up for myFREE hypnobirthing masterclasses:⁠⁠⁠⁠⁠ click here⁠⁠⁠⁠⁠Join my mailing list:⁠⁠⁠⁠⁠ substack.com/@meganmarybirthmotherLove the podcast? support me by leaving a tip via buy me a ko-fi:⁠⁠⁠⁠⁠⁠⁠⁠ko-fi.com/thedungareedoula⁠⁠⁠⁠⁠⁠⁠⁠Book a Power Hour:⁠⁠⁠⁠⁠⁠⁠⁠calendly.com/thedungareedoula/power-hour?month=2024-02⁠⁠⁠⁠⁠⁠⁠⁠If you enjoyed the episode please give it a like, review and click follow so you never miss out!New episodes are out every Friday at 7am so stick around.Connect with me:⁠⁠⁠⁠⁠⁠⁠⁠thedungareedoula.co.uk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/meganmarybirthmother

   We learned Thursday that Bill Self was taken to the hospital again for another heart procedure making it at least three times in four years.  A full recovery is expected after two more stents were inserted.  But what we didn't know is that Self has been coaching with a PICC line... a catheter to deliver medicine and nutrition to his heart.  We have the details and the ask the big question about this legendary coach.    In Columbia, Eli Drinkwitz gets a long contract extension but didn't take much of a raise.  Intstead, he got double the amount he can pay his assistants.  You have to love this guy.   Trump is headed to Scotland for five days after touring the Federal Reserve HQ and Jerome Powell on Thursday.  We were surprised there weren't more fireworks.    Chuck E. Cheese was hauled out of the famous pizza place in Florida and arrested by police.... right in front of all the kids.      And we remember the great Hulk Hogan and tie it in to the Song of the Week.

Message our hosts, Kieran and Jose.Season 3 of The Animal Heartbeat is all about the Veterinary Cardiology Icons - those who walk among us as legends of the veterinary cardiology world.This episode features Professor Chris Orton of Colorado State University. Prof Orton has been a leader in the field of canine heart surgery for over thirty years, having worked to develop both open heart surgery techniques on cardiopulmonary bypass and minimally invasive techniques to treat valve disease. Chris is known as a cardiologist and a surgeon, but also has a strong bench-top research background, evaluating the mitral valve and the mechanisms of degenerative disease.Join our hosts, Jose and Kieran, as they discuss Prof Orton's research experience and his experience over the last 3-years of trans-catheter edge-to-edge mitral valve repair, patient considerations and outcomes.

Interview with Anne P. Cameron, MD and Glenn T. Werneburg, MD, PhD, authors of Foley Catheter Management: A Review. Hosted by Amalia Cochran, MD. Related Content: Foley Catheter Management

In today's VETgirl online veterinary continuing education podcast, Amanda M. Shelby, RVT, VTS (Anesthesia & Analgesia) and Dr. Amy Kaplan-Zattler, cVMA, DACVECC, MRCVS discuss all things IV catheter placement and care. Tune in to hear about Dr. Kaplan and Amanda's talk about their findings and preference on catheter flush frequency, heparin or non-hepatized saline for flush, aseptic scrub techniques and more!

In today's VETgirl online veterinary continuing education podcast, Amanda M. Shelby, RVT, VTS (Anesthesia & Analgesia) and Dr. Amy Kaplan-Zattler, cVMA, DACVECC, MRCVS discuss all things IV catheter placement and care. Tune in to hear about Dr. Kaplan and Amanda's talk about their findings and preference on catheter flush frequency, heparin or non-hepatized saline for flush, aseptic scrub techniques and more!

In this piece we discuss the intricacies of right heart failure, the differences between the right and left ventricles, and the challenges of early detection and monitoring. With a focus upon research we discuss the Swan-Ganz IQ pulmonary artery catheter, with the FastCCO algorithm, from BD Advanced Patient Monitoring. We cover its innovative capabilities, explore its impact on patient care and look particularly at high-risk patients like those with pulmonary hypertension and LVADs. The episode highlights the importance of new monitoring techniques, future research directions, and the promise of continuous data in improving right ventricular function diagnosis and treatment. Presented by Kate Leslie with her guest Joerg Ender, Director of the Department for Anesthesiology and Intensive Care Medicine, Heart Center, Leipzig, Germany. He is second president of the German Society of Anesthesiology and Intensive Care Medicine and former Secretary General of the European Association of Cardiothoracic Anaesthesiologists (EACTA).

In the US, an estimated 70-75% of women who give birth use an epidural for pain relief during labor. Epidural anesthesia during labor can affect bladder function by delaying the return of bladder sensation and potentially leading to urinary retention. This can be due to the nerves that control bladder function being affected by the epidural, reducing the sensation of bladder fullness and the urge to urinate. Intrapartum, there is no universal guidance regarding bladder management with labor epidural analgesia (LEA). Does one method of bladder care intrapartum affect mode of delivery more than the other? Is it better to have an indwelling catheter or to perform intermittent caths. What about patient self-voiding with a bedpan. Let's summarize the data.

In this episode, Carla Hackett shares her three very different birth experiences - from a hospital birth with her first son Raph, to an unexpectedly rapid home birth with her second son Noah, and finally a beautiful water birth with her daughter Maeve. ___________ Download our free guide: Labour tips for birth partners What is a birth support partner? A birth support partner offers physical and emotional support throughout labour and birth. Your birth partner should be mentioned in your birth plan, particularly in regards to how they will advocate for you to your midwife or doctor. If you are a birth partner, don’t forget that she will be relying on you throughout all stages of labour and birth to offer words of encouragement, hold her hand, guide her through breathing techniques and remind her, most importantly, that she is safe.See omnystudio.com/listener for privacy information.

Everything is more fun with a CRAZY STRAW!We're going to start unlock premium episodes as we pick up new members - Enjoy this episode and sign up for the premium version of Terrible Person so you don't miss a thing   ↓ GET TERRIBLE PERSON PREMIUM HERE ↓ http://www.terribleperson.co OR ↓Get the Premium Eps on Patreon ↓https://www.patreon.com/TerriblePersonPremium

We learn the vanishing art of placing the PA (Swan-Ganz) catheter, with intensivist and friend of the podcast Matt Siuba (@msiuba). Learn more at the Intensive Care Academy! Find us on Patreon here! Buy your merch here! Takeaway points References Insertion video Wedge distance How measurement technique affects diagnosis Thermo in TR review POCUS for … Continue reading "Lightning rounds 50: Mastering PA catheter placement with Matt Siuba"

Googly looking weirdo. Idiot Idiom. Six million dollar mom. Vaguely racist, but I don't know how. Broken Nose Specialist. A Whole Lotta Nekkid Goin' On. See you Soup. Crossing The International Punchline. I Don't Like Food That's Chineeeeeeeeeeese. Because When You're Here, You're White. A Perfect Read of a Terrible Write. Never turn down a wedge. Catheter talk. Oscar Baited. Whenever someone learns something, Bobby's hair grows 2 inches and more on this episode of The Morning Stream. Hosted on Acast. See acast.com/privacy for more information.

Googly looking weirdo. Idiot Idiom. Six million dollar mom. Vaguely racist, but I don't know how. Broken Nose Specialist. A Whole Lotta Nekkid Goin' On. See you Soup. Crossing The International Punchline. I Don't Like Food That's Chineeeeeeeeeeese. Because When You're Here, You're White. A Perfect Read of a Terrible Write. Never turn down a wedge. Catheter talk. Oscar Baited. Whenever someone learns something, Bobby's hair grows 2 inches and more on this episode of The Morning Stream. Hosted on Acast. See acast.com/privacy for more information.

Join CardioNerds EP Council Chair Dr. Naima Maqsood and Episode Lead Dr. Jeanne De Lavallaz as they discuss the results of the VANISH2 Trial with expert faculty Dr. Jeff Healey and Dr. Roderick Tung. Audio editing by CardioNerds academy intern, Grace Qiu. The VANISH2 trial enrolled 416 patients with ischemic cardiomyopathy, an ICD in place, and recurrent episodes of sustained monomorphic ventricular tachycardia (VT) to receive either first-line VT catheter ablation or antiarrhythmic drug therapy with the primary composite outcome of death from any cause, appropriate ICD shock, ventricular tachycardia storm (meaning at least 3 ventricular tachycardia events within 24hrs) or treated ventricular tachycardia below the detection limit of the ICD. The study population had a mean age of 68 years, with 94% being men and predominantly of white ethnicity. On average, 14 years had elapsed since their last myocardial infarction, with approximately 60% having undergone percutaneous coronary intervention at the time. The mean ejection fraction was 34%. This episode was planned in collaboration with Heart Rhythm TV with mentorship from Dr. Daniel Alyesh and Dr. Mehak Dhande. CardioNerds Journal Club PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! References - VANISH2 Trial Sapp, J. L., Tang, A. S. L., Parkash, R., Stevenson, W. G., Healey, J. S., Gula, L. J., Nair, G. M., & the VANISH2 Study Team. (2025). Catheter ablation or antiarrhythmic drugs for ventricular tachycardia. The New England Journal of Medicine, 392, 737–747.